The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon
MAXIMILIANSTRASSE 11, 80539 MUNICH, GERMANY
Tel:
Work +49 89 20 30 60 00
Fax:
Fax +49 89 20 30 61 00
Web:
www.kirkland.com
London, Munich

Deutschland: Gesellschaftsrecht und M&A

M&A - mittelgroße Deals (-€500m)
M&A - mittelgroße Deals (-€500m) - ranked: tier 5

Kirkland & Ellis International LLP

Kirkland & Ellis International LLP ist vor allem für Private Equity-Transaktionen bekannt. Die gute Integration mit den internationalen Büros sorgt für einen steten Mandatsfluss. So war an der Beratung des Fahrzeugkomponentenherstellers Accuride bei der Übernahme von Mefro Wheels beispielsweise auch das Londoner Büro beteiligt. Jörg Kirchner, Benjamin Leyendecker und Volkmar Bruckner werden empfohlen.

[von unten nach oben]

Deutschland: Private Equity

Private Equity - Transaktionen
Private Equity - Transaktionen - ranked: tier 2

Kirkland & Ellis International LLP

Die Private Equity-Praxis von Kirkland & Ellis International LLP agiert von München aus und fokussiert sich auf die Sponsoren-Beratung, die auf einer engen Kooperation mit Kollegen aus den Restrukturierungs-, Finanz-, Steuerrechts- und Kapitalmarktrechtspraxen basiert. Benjamin Leyendecker und Attila Oldag, der das Team im Sommer 2017 verstärke und zuvor bei Gütt Olk Feldhaus tätig war, berieten den Fonds Oakley Capital Private Equity III beim Erwerb der Career Partner Group von der Apollo Education Group, während Volkmar Bruckner Oaktree Capital Management beim Erwerb einer Beteiligung an der NL-Holding betreute. Zudem unterstützten Bernhard Guthy und Praxisgruppenleiter Jörg Kirchner Silverfleet Capital beim Verkauf der Competence Call Centre Group (CCC) an den französischen MidCap-Private-Equity-Investor Ardian. Bain Capital, Bregal Unternehmerkapital und Vestigo Capital gehören ebenfalls dem Mandantenstamm an. Finanzierungsexpertin Christine Kaniak stieg im Juli 2018 bei Orrick, Herrington & Sutcliffe LLP als Salary Partnerin ein.

Führende Namen

Jörg Kirchner - Kirkland & Ellis International LLP

[von unten nach oben]

Deutschland: Restrukturierung und Insolvenz

Restrukturierung
Restrukturierung - ranked: tier 1

Kirkland & Ellis International LLP

Die vor allem bei Finanzrestrukturierungen und in der Gläubigerberatung tätige Kanzlei Kirkland & Ellis International LLP nutzte auch jüng ihr international operierendes Netzwerk und konnte somit beispielsweise den um €7 Milliarden verschuldeten, mit 60000 Mitarbeitern größten Einzelhandelskonzern des Balkans, Agrokor, bei der Aufnahme einer Zwischenfinanzierung in Höhe von bis zu €1,1 Milliarden beraten. Dabei arbeitete der angesehene Leo Plank, der neben Bernd Meyer-Löwy und Sacha Lürken die Praxis leitet, mit der Londoner Praxis zusammen. Daneben gehören die Vertretung von Anleihegläubigern im Insolvenzverfahren der Air Berlin, die Vertretung dreier Großgläubiger von Wandelschuldverschreibungen in Höhe von €2,5 Milliarden im Fall Steinhoff Europe, sowie die Mandatierung durch den Spielwareneinzelhändler Toys R US bezüglich des US-amerikanischen Chapter 11 Verfahrens und einer bis zu $3,125 Milliarden Debtor-in-Possession-Finanzierung (DIP) zum umfassenden Mandatsportfolio der aus fünf Partnern bestehenden Praxisgruppe.

Führende Namen

Leo Plank - Kirkland & Ellis International LLP

[von unten nach oben]


Weitere Informationen über Kirkland & Ellis International LLP

Bitte wählen Sie von der folgenden Liste, um unsere Kommentare zu Kirkland & Ellis International LLP anderen Jurisdiktionen zu betrachten.

Co-Publishing weltweit

Rechtsentwicklungen und Neuigkeiten der führenden Anwälte in verschiedenen Jurisdiktionen. Für Beitrüge schicken Sie bitte eine Anfrage per Email an
  • China Drug Registration Regulation - Public consultation on amendment closes - March 2014

    In February 2014, the China Food and Drug Administration (“CFDA”) invited second-round comments from the public regarding proposed amendments to the China Drug Registration Regulations (“DRR”). One of the proposed amendments touches upon patent protection for drugs in China.
  • Revised NDRC Measures for Approval and Filing of Outbound Investment Projects - April 2014

    The National Development and Reform Commission ( NDRC ) released a new set of Management Measures for Approval and Filing of Outbound Investment Projects ( 境外投资项目核准和备案管理办法) ( New Measures ) on 8 April 2014. The New Measures take effect on 8 May 2014 and will replace the Interim Management Measures for Approval of Outbound Investment Projects ( 境外投资项目核准暂行管理办法) ( Original Measures ) which have been in force since 9 October 2004.
  • Insurance Update - CIRC Issues Insurance M&A Measures: What are the impacts and applications?

    On 21 March 2014, CIRC issued the Administrative Measures on the Acquisition and Merger of Insurance Companies (the Insurance M&A Measures ) which will take effect from 1 June 2014. The Insurance M&A Measures apply to M&A activities whereby an insurance company is the target for a merger or acquisition. The target insurance company could be either a domestic or a foreign invested insurer. However, the Insurance M&A Measures will not apply to any equity investment by insurance companies in non-insurance companies in China or in overseas insurance companies.
  • China issues new rules to regulate medical devices - May 2014

    The Regulations on Supervision and Administration of Medical Devices (in Chinese《医疗器械监督管理条例》, State Council Order No. 650) (the Medical Device Regulations) were amended by China's State Council on 31 March 2014 and will come into effect on 1 June 2014. This is the first amendment in more than a decade since the Medical Device Regulations were first promulgated in 2000, even though the amendment was initiated eight years ago in 2006. The 2014 amendment unveils reforms on the regulatory regime for medical devices market in China from various aspects.
  • Hong Kong: The evolving role of independent non-executive directors - May 2014

     In a recent speech given by Mr. Carlson Tong, Chairman of the Securities and Futures Commission, Mr. Tong pointed out that companies can improve corporate governance by attaching higher importance to the role of their board of directors as an internal gatekeeper. Mr. Tong said that this can be done more easily by having effective independent non-executive directors (INEDs) on the board.
  • Walking a fine line in China:Distinguishing between legitimate commercial deals and commercial bribe

    China in the 21st century exemplifies an atmosphere of great opportunity and intense competition. Against this backdrop, it has become increasingly common for businesses to adopt a variety of practices in order to make their products and services competitive. Such practices may include paying middle-men to promote sales and giving incentives to buyers directly. However, whilst revenue spikes are undoubtedly welcome, businesses should bear in mind the potential backlash arising out of these commercial arrangements. The risk that such arrangements may not comply with anti-bribery and corruption laws and therefore cause business significant damage in the long term should not be underestimated.
  • Competition law developments in East Asia - May 2014

    Authorities in Hong Kong have taken further steps in their deliberate approach to enforcing the Competition Ordinance. A little over a year after it was appointed, the Competition Commission released a report in which it provides a brief introduction to the Ordinance as well as a roadmap leading to its full entry into force. The report also explains how the Commission will prioritise its enforcement activities, and identifies the guidelines, policies and compliance tools which it plans to release before the Ordinance is enforced. Currently only some of the institutional provisions of the Ordinance are effective, allowing the Commission and the Competition Tribunal to prepare for enforcement.
  • Rise of the private healthcare sector - July 2014

    As of 2013, China had 9,800 private hospitals, representing almost half of the total number of hospitals in the country 1 . However, private hospitals still severely lag behind their public peers due to low utilisation, talent shortages and incomplete social insurance coverage. As part of China's ongoing healthcare reform initiatives, the Chinese government has set a goal to increase the share of patients treated by private hospitals to 20% by the end of 2015 2 .
  • Walking a Tightrope in Singapore - July 2014

    The world has no borders and distance is negligible for the technologically savvy criminal. Individuals with illicit funds to launder or terrorist activities to finance can, with the latest technology, transfer high volumes of money around the globe almost instantaneously and seek to conceal the origin or the destination of the funds.
  • Indonesia banking bill: proposed restrictions on foreign investment - July 2014

    Indonesia's House of Representatives is currently considering a new draft banking bill (the Banking Bill ) which, if passed into law in its current form, will: